跳转至内容
Merck
CN

05-678

抗泛素组蛋白H2A抗体,克隆E6C5

clone E6C5, Upstate®, from mouse

别名:

H2AUb, Histone H2A (ubiquityl), H2A histone family, member R, histone 1, H2aa, histone H2A, histone cluster 1, H2aa, H2AK119Ub1

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

抗泛素组蛋白H2A抗体,克隆E6C5, clone E6C5, Upstate®, from mouse

biological source

mouse

conjugate

unconjugated

antibody form

purified antibody

antibody product type

primary antibodies

clone

E6C5, monoclonal

species reactivity

amphibian, mouse, human, frog, rat, monkey

manufacturer/tradename

Upstate®

technique(s)

ChIP: suitable
immunocytochemistry: suitable
western blot: suitable

isotype

IgM

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

Gene Information

frog ... H2Ac1(594915)
human ... H2AC1(221613)
mouse ... H2Ac1(319163)
rat ... H2Ac1(24828)

Analysis Note

对照
HeLa细胞的酸提取物
通过蛋白质印迹法对HeLa和10T1/2细胞的酸提取物中的H2A进行了常规评估。

蛋白质印迹分析:
该批次以1:500-1:2000的稀释度在HeLa和10T1/2细胞的酸提取物中检测到泛素组蛋白H2A。

Application

使用抗泛素-组蛋白H2A抗体,克隆E6C5(小鼠单克隆抗体)已发表并经验证可用于ChIP、ICC、WB,以检测泛素-组蛋白H2A(也称为H2AUb、组蛋白H2A(泛素)、组蛋白H2A)。
免疫细胞化学:
该抗体已由独立实验室报告用于检测用3%甲醛/0.1% Triton X-100或甲醇固定的细胞中的泛素组蛋白H2A(Vassilev,A.1995)。

染色质免疫沉淀:
由独立实验室报告(Wang, H. 2004)。
研究子类别
组蛋白
研究类别
表观遗传学&核功能

Biochem/physiol Actions

不与粘虫发生交叉反应。
其他物种还未经测试。
该抗体识别并特异于单泛素组蛋白H2A(Lys119),Mr~25 kDa。

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

General description

25 kDa
组蛋白是高度保守的蛋白质,可作为将核DNA组织成染色质的结构支架。组蛋白在翻译后通过乙酰化、磷酸化、甲基化和泛素化进行修饰,这些修饰调节DNA转录、修复、重组和复制。泛素化通常靶向降解的底物,尽管组蛋白H2A和H2B实际上通过单个泛素结合而稳定。 组蛋白泛素化与DNA修复和转录,细胞分化,细胞周期调控,精子发生,蛋白质运输以及对压力的反应有关。 组蛋白H2A在Lys119处被PRC-1L复合物(Polycomb repressive complex 1-like)单泛素化,该复合物包括Ring1,Ring2,Bmi1和HPH2。 泛素化的H2A通常占H2A的约15%,但在活性染色质中该值可高达50%。 泛素化组蛋白H2A也与大染色质区域的转录沉默有关,并与Polycomb沉默有关,因此泛素化H2A的功能仍然不确定。

Immunogen

AMA(人上皮羊膜)细胞残留核团部分。

Other Notes

浓度:请参考批次特异性浓缩物的分析证书。

Physical form

形式:纯化
纯化的小鼠单克隆IgM溶于缓冲液(含0.05%叠氮化钠的PBS)中,然后添加甘油至30%。在-20ºC为液体形式。

Preparation Note

自收到之日起在-20°C可稳定保存1年。 为了最大程度地回收产品,在取下盖子之前,将原始样品瓶进行离心。

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Genome-wide uH2A localization analysis highlights Bmi1-dependent deposition of the mark at repressed genes.
Kallin, EM; Cao, R; Jothi, R; Xia, K; Cui, K; Zhao, K; Zhang, Y
PLoS Genetics null
Yanlai Lai et al.
Archives of biochemistry and biophysics, 518(2), 103-110 (2012-01-12)
Inactivation of the von Hippel-Lindau (VHL) tumor suppressor is associated with renal carcinoma, hemangioblastoma and pheochromocytoma. The VHL protein is a component of a ubiquitin ligase complex that ubiquitinates and degrades hypoxia inducible factor-α (HIF-α). Degradation of HIF-α by VHL
Wei-Ting Liao et al.
Carcinogenesis, 30(6), 1064-1072 (2009-04-21)
Bowen's disease (BD), a carcinoma in situ of the skin, has been identified as an early lesion in arsenic carcinogenesis. Patients with arsenic-induced Bowen's disease (As-BD) showed both cutaneous and systemic immune dysfunctions. We set out to evaluate the interactions
Hideyuki Oguro et al.
The Journal of experimental medicine, 209(3), 445-454 (2012-02-22)
Polycomb-group (PcG) proteins form the multiprotein polycomb repressive complexes (PRC) 1 and 2, and function as transcriptional repressors through histone modifications. They maintain the proliferative capacity of hematopoietic stem and progenitor cells by repressing the transcription of tumor suppressor genes
Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activity.
Qingdong Ke, Thomas P Ellen, Max Costa, Qingdong Ke, Thomas P Ellen, Max Costa
Toxicology and Applied Pharmacology null

相关内容

Signaling Product Guide: Antibodies, small molecule inhibitors, kits, assays and proteins for signaling research.

"Epigenetics describes heritable changes in gene expression caused by non-genetic mechanisms instead of by alterations in DNA sequence. These changes can be cell- or tissue-specific, and can be passed on to multiple generations. Epigenetic regulation enriches DNAbased information, allowing a cell to vary its response across diverse biological and environmental contexts. Although epigenetic mechanisms are primarily centered in the nucleus, these mechanisms can be induced by environmental signals such as hormones, nutrients, stress, and cellular damage, pointing to the involvement of cytoplasmic and extracellular factors in epigenetic regulation."

Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持